Ethics & Informed Consent: Qualitative Interview & Focus Group Research (Singapore)
A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Qualitative Interview & Focus Group Research within the regulatory framework of Singapore.
1. Ethical Principles & Legislative Framework
In research involving human participants, securing ethical clearance is a critical first step. For a Qualitative Interview & Focus Group Research being conducted in Singapore, study designs must align with the primary regulatory legislation: Human Biomedical Research Act (HBRA). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.
National Ethics Board Clearance Pathway
In Singapore, human biomedical research is governed by the Human Biomedical Research Act (HBRA), which defines strict penalties for non-compliance. Ethical clearance must be obtained from an institutional IRB or an appointed Institutional Ethics Committee. Personal data protection must adhere to the Personal Data Protection Act (PDPA), which governs the collection, use, and disclosure of personal data for research.
Administrative review and formal approval are managed by a local or regional Institutional Review Board (IRB). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.
2. Study Design Elements & Reporting Integrity
For a Qualitative Interview & Focus Group Research, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.
Study Classification: Minimal Risk
Qualitative research relies on dialogue. The consent process must guarantee that names and highly specific personal identifiers will be removed from final reports. Participants must be informed that focus group co-participants cannot guarantee complete confidentiality.
To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: COREQ checklist.
Special Directive: Observational Study Protocols
As an observational or non-interventional design, the ethics board primarily focuses on data privacy, secure pseudonymisation, and informed consent. If you are conducting retrospective database research, you may apply for a waiver of consent, provided participant risk is minimised.
3. Informed Consent & Information Sheet Guidelines
A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:
Design-Specific Consent Focus Areas
Explicit consent for audio/video recording, publication of anonymised verbatim quotes, and focus group privacy rules.
- Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
- Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
- Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Personal Data Protection Act (PDPA).
- Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
- Ethics Board Contact Information: Provide the contact details of the reviewing Institutional Review Board (IRB) so participants can reach out if they have questions or concerns.
Research Ethics, Clinical Trials & Institutional Governance
Applying the Declaration of Helsinki ethical principles to this qualitative Qualitative Interview & Focus Group Research means respecting participant self-determination. Any study requiring any deception in psychological research must be pre-approved by the Institutional Review Board (IRB) with a thorough debriefing plan. The consenting workflow must actively support the ethical principles of informed consent, ensuring full transparency. Although qualitative designs do not require a clinical trial registration, securing a signed clinical trial agreement contract is often required for hospital sites. Submitting a robust data privacy plan is the final step to secure complete research ethics approval from the Institutional Review Board (IRB). Ethical oversight committees in Singapore audit the study's consent registry periodically to verify compliance with national legal statutes.
4. Regulatory Checklist Table
To streamline your ethical review submission, use the structured alignment checklist below:
| Requirement | Institutional Review Board (IRB) Standard | COREQ checklist Standard |
|---|---|---|
| Consent Form | Signed and dated prior to study activity. Focus: Explicit consent for audio/video recording. | Fully documented recruitment and consent paths. |
| Risk Management | Comprehensive risk mitigation plan. Pseudonymisation of interview transcripts, secure digital recording storage, prompt deletion of raw audio files post-transcription. | Adverse events reporting strategy. |
| Data Retention | Compliance with local data protection rules (Personal Data Protection Act (PDPA)). | Provision of open-data options where possible. |
5. Academic & Research Infrastructure Matrix (Singapore)
The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Singapore mapped via the Research Organization Registry (ROR) standards-compliance framework.
| Organization Name | Sector Type | Registry Identification |
|---|---|---|
| Singapore Telecommunications Limited | company | ROR ID |
| Medtronic (Singapore) | company | ROR ID |
| MediaTek (Singapore) | company | ROR IDWikidata/Wiki |
| Sivantos (Singapore) | company | ROR IDWikidata/Wiki |
| Siemens (Singapore) | company | ROR IDWikidata/Wiki |
| Danaher (Singapore) | company | ROR IDWikidata/Wiki |
| Abbott (Singapore) | company | ROR IDWikidata/Wiki |
| AstraZeneca (Singapore) | company | ROR IDWikidata/Wiki |
| Merck (Singapore) | company | ROR IDWikidata/Wiki |
| Takeda (Singapore) | company | ROR IDWikidata/Wiki |
| Advantest (Singapore) | company | ROR IDWikidata/Wiki |
| Safran (Singapore) | company | ROR IDWikidata/Wiki |
| GlobalFoundries (Singapore) | company | ROR IDWikidata/Wiki |
| TDK (Singapore) | company | ROR IDWikidata/Wiki |
| Hillrom (Singapore) | company | ROR IDWikidata/Wiki |
6. Frequently Asked Questions
How long does the review process normally take?
Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Singapore takes between 4 to 8 weeks.
Can we use digital signatures for informed consent?
Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.
Regulatory Context
Verified Funding Bodies
Funder registries and DOI configurations verified for compliance in Singapore via Crossref.
- Singapore Police ForceID: 501100001472 | Location: Singapore
- Economic Development Board - SingaporeID: 501100001446 | Location: Singapore
- Health Promotion Board - SingaporeID: 501100001448 | Location: Singapore
- Public Utilities Board - SingaporeID: 501100001467 | Location: Singapore
- Singapore's National Water AgencyID: 501100018705 | Location: Singapore
- Singapore Institute of TechnologyID: 100031556 | Location: Singapore
- National Library Board - SingaporeID: 501100001465 | Location: Singapore
- Ministry of Health -SingaporeID: 501100001350 | Location: Singapore
- Precision Health Research, SingaporeID: 501100022247 | Location: Singapore
- Singapore-ETH CentreID: 501100015833 | Location: Singapore
Pre-Submission Warning
Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under Human Biomedical Research Act (HBRA).







